LINC02322: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC02322

NCBI ID: G101927729

LINC02322

Other Name(s): long intergenic non-protein coding RNA 2322 | Long intergenic non-protein coding RNA 2322

LINC02322: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC02322 is a long non-coding RNA (lncRNA) that has been identified in various studies as having various functionalities, including the regulation of gene expression, DNA replication, and chromatin remodeling. Its unique feature is its ability to interact with DNA, as well as its involvement in the regulation of splicing. These properties make LINC02322 an attractive candidate for potential drug targets or biomarkers.

Drug Target Potential

LINC02322 has been shown to play a role in the regulation of cell proliferation and apoptosis. It has been shown to promote the growth of cancer cells and contribute to their survival. Additionally, LINC02322 has been associated with the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Therefore, targeting LINC02322 as a drug target may have potential therapeutic benefits for these diseases.

Biomarker Potential

LINC02322 has also been shown to be involved in the regulation of gene expression and protein translation. It has been shown to interact with various proteins, including the transcription factors, to enhance their activity and promote gene expression. This interaction between LINC02322 and proteins involved in gene regulation may make it an attractive biomarker for the diagnosis and monitoring of various diseases.

Antagonistic Interactions with Other Proteins

LINC02322 has also been shown to interact with various proteins involved in cellular signaling pathways, including the NF-kappa pathway. This interaction may make LINC02322 a potential target for drugs that are currently used to treat conditions such as cancer, neurodegenerative diseases, and developmental disorders.

Conclusion

In conclusion, LINC02322 is a long non-coding RNA that has various functionalities, including the regulation of gene expression, DNA replication, and chromatin remodeling. Its ability to interact with DNA and its involvement in the regulation of splicing make it an attractive candidate for potential drug targets or biomarkers. The potential therapeutic benefits of targeting LINC02322 as a drug target or biomarker for various diseases make it a promising area of research.

Protein Name: Long Intergenic Non-protein Coding RNA 2322

The "LINC02322 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02322 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets